Alan W. Tamarelli

Partner
atamarelli@cooley.com
Full contact info

About Alan

Alan’s practice focuses on the representation of biotech, pharma, medical device and other life sciences companies in connection with technology-driven strategic transactions. He advises companies on research collaborations and development agreements, intellectual property and technology licensing agreements, and commercial collaborations, including joint ventures, profit-sharing arrangements and co-promotion agreements. He also has experience with manufacturing, distribution, supply and quality agreements, clinical trial agreements, M&A transactions, and life sciences industry-specific matters and counseling.

View full bio

Experience

COUR Pharmaceuticals Secures $105 Million Series A

COUR Pharmaceuticals Secures $105 Million Series A

January 30, 2024

Cooley advised COUR Pharmaceuticals, a clinical-stage biotechnology company focused on the development of first-in-class disease-modifying therapies designed to induce antigen-specific tolerance for immune-mediated diseases, on the close of its $105 million Series A financing.

Read more

Related contacts

Winston Gu
Partner, Chicago
Marc Recht
Partner, Boston
Christina T. Roupas
Partner in Charge – Chicago, Chicago
Yvan-Claude Pierre
Partner, New York
Grant L. Page
Associate, Los Angeles Santa Monica
Andrew Mettry
Associate, Chicago
Jeffrey J. Tolin
Partner, New York
Blake Martell
Partner, San Francisco
John Sellers
Partner, Palo Alto
Alan W. Tamarelli
Partner, New York
Bin Wang
Special Counsel, Palo Alto
Annie Froehlich
Partner, Washington, DC
Erica Russell
Associate, San Francisco
Calvin Lee
Associate, New York
Andrew Bae
Associate, Washington, DC
Zack Gong
Associate, Shanghai
Miriam Petrillo
Partner, Chicago

Related Practices & Industries

Emerging Companies
Venture Capital
Capital Markets
Biotechnology
Healthcare
Life Sciences
Life Sciences Corporate Partnering and Licensing
CFIUS
Compensation and Benefits
Tax

Cooley Supports Jiangsu Hengrui in Two Global License Agreements

Cooley Supports Jiangsu Hengrui in Two Global License Agreements

November 8, 2023

Cooley advised Jiangsu Hengrui Pharmaceuticals, a leading global pharmaceutical company headquartered in China with a focus on research, development, manufacturing and commercialization of innovative and high-quality healthcare products, on its strategic collaboration and exclusive worldwide (excluding mainland China) license agreement with Merck KGaA, Darmstadt, Germany and global license agreement (excluding the Greater China region and Korea) with Elevar Therapeutics.

Read more

Related contacts

Christina Zhang
Partner, Shanghai
Freddy Yip
Associate, Hong Kong
Alan W. Tamarelli
Partner, New York
Bin Wang
Special Counsel, Palo Alto
Bill Christiansen
Partner, Seattle
Dr. Xixi Sun
Associate, Boston
Amanda Pacheco
Associate, Palo Alto
Brendan Haberle
Associate, San Diego
Howard Morse
Partner, Washington, DC

Related Practices & Industries

Life Sciences
Life Sciences Corporate Partnering and Licensing
Life Sciences and Healthcare Regulatory
Healthcare
Patent Counseling and Prosecution – Life Sciences
Tax
Antitrust and Competition

Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II

Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II

December 9, 2021

Cooley advised Alvotech Holdings, a global biopharmaceutical company focused on the development and manufacturing of biosimilar medicines for patients worldwide, on its agreement to merge with special purpose acquisition company (SPAC) Oaktree Acquisition Corp. II. Lawyers Michal Berkner, Div Gupta, Nicolas Dumont and Jarrett Burks led the Cooley team advising Alvotech.

Read more

Related contacts

Div Gupta
Partner, New York
Nicolas H.R. Dumont
Partner, New York
Jarrett Burks
Associate, London
Vlad Herta
Associate, London
Wouter Deleersnyder
Associate, New York
Sonia Nath
Partner, Washington, DC
Elizabeth Anne Wright
Of Counsel, Brussels
Phil Mitchell
Partner, New York
Aaron Pomeroy
Partner, Colorado
Barbara Mirza
Partner, Los Angeles Santa Monica
Stacey A. Bradford
Special Counsel, Washington, DC
Rick Jantz
Associate, Los Angeles Santa Monica
Stella Sarma
Special Counsel, Brussels
Jennifer Shanley
Special Counsel, New York
Ivor Elrifi
Partner, New York
Sharon Connaughton
Special Counsel, Washington, DC
Alexandria Ashour
Associate, San Diego
Chris Coulter
Partner, London
David Dalton
Associate, Los Angeles Santa Monica
Neelam Atwal
Associate, London
Chris Stack
Partner, London
Alan W. Tamarelli
Partner, New York
Karen Tsai
Special Counsel, Washington, DC
Wyatt Kernell
Associate, New York
Reid Hooper
Special Counsel, Washington, DC
Megan Browdie
Partner, Washington, DC
Sanya Sukduang
Partner, Washington, DC
Alessandra Murata
Partner, Palo Alto
Natasha Leskovsek
Of Counsel, Washington, DC
James Maton
Partner, London
Shehzad Akram
Trainee Solicitor , London
Sarah Oliai
Associate, Washington, DC
Barbara Borden
Partner, San Diego
Nicola Squire
Partner, London
Peter Byrne
Partner, New York
Claire Keast-Butler
Partner, London
Jill Simon
Senior Paralegal, New York
Xander Lee
Partner, Los Angeles Santa Monica
Calvin Lee
Associate, New York

Related Practices & Industries

Mergers and Acquisitions
Life Sciences
Life Sciences Corporate Partnering and Licensing
Antitrust and Competition
Capital Markets
Compensation and Benefits
Labor and Employment
Healthcare
Export Controls and Economic Sanctions
Government Contracts
Intellectual Property Litigation
Public Companies
Tax
Technology Transactions

Admissions & credentials

Massachusetts

New York

Pennsylvania

Rankings & accolades

Legal 500 US: Recommended for Commercial Deals and Contracts (2018)

Legal 500 US: Recommended for Technology Transactions (2018)